Lenacapavir is a drug manufactured by Gilead Sciences that was referred to as a “breakthrough” by health organizations. On November…
Read More
Patents vs Patients: How TRIPS Shapes Global Access to Medicine
Access to life-saving medicine is often framed as a scientific issue, one that’s dependent on discovering new drugs, innovating treatments,…
Read More
How Global Policy Fuels Antimicrobial Resistance
Antimicrobial resistance (AMR) has been especially prevalent in recent years and is now becoming one of the most pressing issues…
Read More
Inaccessibility to Medicine in the Rohingya Refugee Camp
Medicine often falls short long before a patient finds their way to a clinic. This is an especially prevalent issue…
Read More
Metformin: New Research Suggests Its Utility Against Atrial Fibrillation
New research out of the American Heart Association has put a focus on metformin, a drug usually used to control…
Read More
Robotic Heart Transplant Marks Breakthrough in Surgery
In an operating room at Baylor St. Luke’s Medical Center in Houston, Texas, surgeons set a historic precedent this spring.…
Read More
Computational Biology: Powering the Future of Pharmacology
Computational biology is transforming pharmacology by facilitating drug discovery, personalizing treatments, and enhancing drug safety. Pharmaceutical companies utilize simulations and…
Read More
Poisoned Promises: The Spread of Counterfeit Medication
Buying the false perception of a malfunctioning options-based medical treatment process, patients are waiting their turn in clinics situated in…
Read More
The Rise of Nicotine Pouch Poisonings in Children
Nicotine pouches have been a rising trend, especially in the U.S., over the course of the 2010s. These pouches are…
Read More
Nanoparticle based Targeted Drug Delivery
Nanoparticle-based drug delivery promises targeted treatment, improving precision medicine by delivering therapeutics directly to diseased tissues while minimizing harm to…
Read More
